Related Experiment Videos
Renal angioplasty: current status
Insights
Percutaneous transluminal angioplasty effectively treats renovascular hypertension caused by renal artery stenosis. This minimally invasive procedure significantly reduces blood pressure in most patients, offering a viable treatment option.
Area of Science:
- Interventional Cardiology
- Nephrology
- Vascular Surgery
Background:
- Renovascular hypertension, caused by renal artery stenosis, is a significant clinical challenge.
- Percutaneous transluminal angioplasty (PTA) has emerged as a key therapeutic modality.
- Increasing frequency of PTA use for managing renal artery stenosis and its complications.
Purpose of the Study:
- To evaluate the efficacy and long-term outcomes of PTA in patients with renovascular hypertension.
- To identify factors influencing the success of PTA in this patient cohort.
- To assess the impact of PTA on blood pressure control and renal function.
Main Methods:
- Retrospective analysis of 140 PTA procedures in 90 patients with 119 renal artery stenoses.
- Inclusion of patients treated for hypertension and/or renal insufficiency.
- Follow-up of blood pressure response for 1-52 months (mean 22 months).
Main Results:
- An initial technical success rate of 95% was achieved.
- Mean diastolic blood pressure decreased by 36.7 mm Hg post-treatment.
- Among 80 hypertensive patients, 25 were cured, 47 improved, and 8 were non-responders.
Conclusions:
- PTA is technically feasible and clinically effective for treating renovascular hypertension.
- Patient selection, appropriate balloon sizing, and initial procedural success are critical for long-term outcomes.
- PTA offers a significant benefit in blood pressure reduction for patients with renal artery stenosis.
Abstract:
Percutaneous transluminal angioplasty has attracted a great deal of attention in recent years and is being used with increasing frequency for the treatment of renovascular hypertension from renal artery stenosis. One hundred forty dilatation procedures have been performed in 90 patients with 119 renal artery stenoses. Ten of the patients were treated for renal insufficiency alone. An initial success rate of 95% was achieved. The blood pressure response has been followed for 1-52 months (mean, 22 months). The mean diastolic pressure decreased by 36.7 mm Hg in response to the treatment. Of the 80 hypertensive patients, 25 were classified as cured, 47 as improved, and eight as nonresponders. Patient selection, the proper balloon size, and a good initial response are the major factors in determining long-term success. Percutaneous transluminal angioplasty is technically feasible and clinically effective for the treatment of renovascular hypertension.